Improving testing for antibiotic-resistant bacteria using advanced sequencing techniques
Official title: Vet-LIRN Network Capacity-Building Project: Bacterial Whole Genome Sequencing
Funded at Louisiana State Univ A&m Col Baton Rouge · NIH-11174148 · Data updated 2026-11-12
This study is looking at how to use advanced DNA testing to better find and track bacteria that are resistant to antibiotics, helping doctors and veterinarians treat infections more effectively and keep everyone healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Louisiana State Univ A&m Col Baton Rouge NIH-funded |
| Lab location | 1 site (Baton Rouge, United States) |
| Project start | July 1, 2018 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $18,750 |
| NIH project number | 3U18FD006442-07S1 |
| Project ID | NIH-11174148 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who are at risk of infections from antibiotic-resistant pathogens, particularly those with compromised immune systems or chronic health conditions.
✕Less likely to help
Patients who do not have any risk factors for antibiotic-resistant infections or who are not currently experiencing any infections may not benefit from this research.
What this research studies
This research focuses on enhancing the capacity for whole-genome sequencing (WGS) to identify and monitor antibiotic-resistant bacteria. By utilizing WGS, the project aims to provide critical data that can help in understanding the genetic makeup of these pathogens, which is essential for effective treatment and infection control. The research will involve collaboration with laboratory networks to ensure rapid detection and response to emerging antibiotic resistance threats, benefiting both human and animal health.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic capabilities and treatment options for infections caused by antibiotic-resistant bacteria.
How similar studies have gone: Previous research has demonstrated the effectiveness of whole-genome sequencing in tracking and managing antibiotic resistance, indicating that this approach has been successful in similar contexts.
Where this research is happening
-
Louisiana State Univ A&m Col Baton Rouge
Baton Rouge, United States Active
Researchers
- Principal investigator: Balasuriya, Udeni B. R. — Louisiana State Univ A&m Col Baton Rouge
- Study coordinator: Balasuriya, Udeni B. R.
Related research
Other NIH-funded projects on the same topics.
-
Bilateral auditory integration and its role in auditory disorders
A study to understand how both ears work together to localize and organize sounds, which could help people with central auditory processing issues.
-
Host glutamine metabolism in tuberculosis pathogenesis
A study tests a drug that blocks host glutamine use to help fight tuberculosis by improving immune cells’ ability to kill the bacteria.
-
Ras signaling and regulatory T cells to treat allergic airway inflammation
A small, patient-friendly study will explore how Ras signaling affects a type of immune cell that helps control allergic inflammation in the airways of people with allergic asthma.
-
Bacterial genome sequencing to boost AMR detection in veterinary-lab networks
A veterinary and public-health project to expand bacterial whole-genome sequencing so labs can quickly identify antibiotic resistance and control outbreaks.
-
Microbes and the body's hormonal signals in a tiny worm
This grant looks at how gut microbes affect hormonal signals that control metabolism, using a tiny worm to model how this could influence type 2 diabetes and related heart and kidney issues.
-
Leptin and fat cells: how obesity may worsen lung infections like COVID-19 and flu
A study explores how fat tissue and the leptin pathway might change the body's first lung defenses during respiratory infections in people who are obese or have diabetes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.